A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

hookworm

Researchers Analyze Genomes of 81 Parasitic Worm Species
Ashley P. Taylor | Nov 5, 2018
The new data could help identify treatments for diseases ranging from river blindness to schistosomiasis.
Image of the Day: Hungry Hookworms
The Scientist Staff, The Scientist Staff | Mar 26, 2018
Researchers discover anti-malarials called quinolones can halt the development of the parasites, offering a potential therapeutic avenue.
Genome Digest
Jenny Rood | Mar 4, 2015
What researchers are learning as they sequence, map, and decode species’ genomes